Cemeli T, Guasch-Vallés M, Ribes-Santolaria M, Ibars E, Navaridas R, Dolcet X, Pedraza N, Colomina N, Torres-Rosell J, Ferrezuelo F et al (2022) Antitumor effects of Ral-GTPases downregulation in glioblastoma. Int J Mol Sci 23(15):8199
Article PubMed PubMed Central CAS Google Scholar
Dhillon S (2020) Tirabrutinib: first approval. Drugs 80:835–840
Article PubMed CAS Google Scholar
Estupiñán HY, Berglöf A, Zain R, Smith CIE (2021) Comparative analysis of BTK inhibitors and mechanisms underlying adverse effects. Front Cell Dev Biol 9:630942
Article PubMed PubMed Central Google Scholar
Gao P, Liu S, Yoshida R, Shi CY, Yoshimachi S, Sakata N, Goto K, Kimura T, Shirakawa R, Nakayama H et al (2019) Ral GTPase activation by downregulation of RalGAP enhances oral squamous cell carcinoma progression. J Dent Res 98:1011–1019
Article PubMed CAS Google Scholar
Gao Y, Gong Y, Liu Y, Xue Y, Zheng K, Guo Y, Hao L, Peng Q, Shi X (2023) Integrated analysis of transcriptomics and metabolomics in human hepatocellular carcinoma HepG2215 cells after YAP1 knockdown. Acta Histochem 125:151987
Article PubMed CAS Google Scholar
George B, Seals S, Aban I (2014) Survival analysis and regression models. J Nucl Cardiol 21:686–694
Article PubMed PubMed Central Google Scholar
Ghoroghi S, Mary B, Larnicol A, Asokan N, Klein A, Osmani N, Busnelli I, Delalande F, Paul N, Halary S, et al. (2021) Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes. Elife 10
Huang G, Xu X, Ju C, Zhong N, He J, Tang XX (2022) Identification and validation of autophagy-related gene expression for predicting prognosis in patients with idiopathic pulmonary fibrosis. Front Immunol 13:997138
Article PubMed PubMed Central CAS Google Scholar
Kozaki R, Vogler M, Walter HS, Jayne S, Dinsdale D, Siebert R, Dyer MJS, Yoshizawa T (2018) Responses to the selective Bruton’s Tyrosine Kinase (BTK) inhibitor tirabrutinib (ONO/GS-4059) in diffuse large B-cell lymphoma cell lines. Cancers (Basel) 10(4):127
Mantovani A, Balkwill F (2006) RalB signaling: a bridge between inflammation and cancer. Cell 127:42–44
Article PubMed CAS Google Scholar
Martin TD, Chen XW, Kaplan RE, Saltiel AR, Walker CL, Reiner DJ, Der CJ (2014) Ral and Rheb GTPase activating proteins integrate mTOR and GTPase signaling in aging, autophagy, and tumor cell invasion. Mol Cell 53:209–220
Article PubMed PubMed Central CAS Google Scholar
Muller S, Tilakaratne WM (2022) Update from the 5th edition of the World Health Organization classification of head and neck tumors Tumours of the oral cavity and mobile tongue. Head Neck Pathol 16:54–62
Article PubMed PubMed Central Google Scholar
Munakata W, Tobinai K (2021) Tirabrutinib hydrochloride for B-cell lymphomas. Drugs Today (Barc) 57:277–289
Article PubMed CAS Google Scholar
Richardson DS, Spehar JM, Han DT, Chakravarthy PA, Sizemore ST (2022) The RAL enigma: distinct roles of RALA and RALB in cancer. Cells 11(10):1645
Article PubMed PubMed Central CAS Google Scholar
Rybko VA, Knizhnik AV, Komelkov AV, Aushev VN, Trukhanova LS, Tchevkina EM (2011) Different metastasis promotive potency of small G-proteins RalA and RalB in in vivo hamster tumor model. Cancer Cell Int 11:22
Article PubMed PubMed Central CAS Google Scholar
Schneider R, Reinau D, Stoffel S, Jick SS, Meier CR, Spoendlin J (2021) Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group. Br J Dermatol 185:343–352
Article PubMed CAS Google Scholar
Seashore-Ludlow B, Rees MG, Cheah JH, Cokol M, Price EV, Coletti ME, Jones V, Bodycombe NE, Soule CK, Gould J et al (2015) Harnessing connectivity in a large-scale small-molecule sensitivity dataset. Cancer Discov 5:1210–1223
Article PubMed PubMed Central CAS Google Scholar
Shi X, Li S, Wang L, Li H, Li Z, Wang W, Bai J, Sun Y, Li J, Li X (2020) RalB degradation by dihydroartemisinin induces autophagy and IFI16/caspase-1 inflammasome depression in the human laryngeal squamous cell carcinoma. Chin Med 15:64
Article PubMed PubMed Central CAS Google Scholar
Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7–33
Song X, Hua L, Xu Y, Fang Z, Wang Y, Gao J, Shi Q, Zhou X, Yu R (2015) Involvement of RalB in the effect of geranylgeranyltransferase I on glioma cell migration and invasion. Clin Transl Oncol 17:477–485
Article PubMed CAS Google Scholar
Tang Z, Kang B, Li C, Chen T, Zhang Z (2019) GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 47:W556-w560
Article PubMed PubMed Central CAS Google Scholar
Thies KA, Cole MW, Schafer RE, Spehar JM, Richardson DS, Steck SA, Das M, Lian AW, Ray A, Shakya R et al (2021) The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer. Breast Cancer Res 23:65
Article PubMed PubMed Central CAS Google Scholar
Tian L, Zhao L, Sze KM, Kam CS, Ming VS, Wang X, Zhang VX, Ho DW, Cheung TT, Chan LK et al (2022) Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma. Hepatology 76:48–65
Article PubMed CAS Google Scholar
Wang H, Owens C, Chandra N, Conaway MR, Brautigan DL, Theodorescu D (2010) Phosphorylation of RalB is important for bladder cancer cell growth and metastasis. Cancer Res 70:8760–8769
Article PubMed PubMed Central CAS Google Scholar
Wang Y, Zheng Y, Chen Q, Dai Y, Li T (2021) MicroRNA-139 inhibits pancreatic-cancer carcinogenesis by suppressing RalB via the Ral/RAC/PI3K pathway. Arch Biochem Biophys 704:108719
Article PubMed CAS Google Scholar
Zago G, Biondini M, Camonis J, Parrini MC (2019) A family affair: a Ral-exocyst-centered network links Ras, Rac, Rho signaling to control cell migration. Small GTPases 10:323–330
Article PubMed CAS Google Scholar
Zago G, Veith I, Singh MK, Fuhrmann L, De Beco S, Remorino A, Takaoka S, Palmeri M, Berger F, Brandon N, et al. (2018) RalB directly triggers invasion downstream Ras by mobilizing the Wave complex. Elife 7
Zhang Q, Li L, Lai Y, Zhao T (2020) Silencing of SPP1 suppresses progression of tongue cancer by mediating the PI3K/Akt signaling pathway. Technol Cancer Res Treat 19:1533033820971306
Comments (0)